• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eliem Therapeutics, Inc - Common Stock (NQ: ELYM )

    5.110 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 5.110
    Bid (Size) 4.950 (5)
    Ask (Size) 5.300 (10)
    Prev. Close 5.110
    Today's Range 5.110 - 5.110
    52wk Range 2.520 - 11.55
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
    From Eliem Therapeutics, Inc.
    Via GlobeNewswire
    Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
    From Eliem Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +82.50%
    +82.50%
    1 Month
    N/A
    N/A
    3 Month
    +0.39%
    +0.39%
    6 Month
    -27.52%
    -27.52%
    1 Year
    +89.26%
    +89.26%

    More News

    Read More
    Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Eliem Therapeutics Announces Additions to its Leadership Team
    From Eliem Therapeutics, Inc.
    Via GlobeNewswire
    ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q2 2024
    Via InvestorPlace
    Eliem Therapeutics Reports Second Quarter Financial Results
    From Eliem Therapeutics, Inc.
    Via GlobeNewswire
    IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
    From Eliem Therapeutics, Inc.
    Via GlobeNewswire
    Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
    From Eliem Therapeutics, Inc.
    Via GlobeNewswire
    ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Nasdaq Jumps 250 Points; Crude Oil Down 1%
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Dow Dips 100 Points; CarMax Earnings Miss Views
    Via Benzinga
    Topics Earnings Stocks
    Exposures Financial US Equities
    Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
    From Eliem Therapeutics, Inc.
    Via GlobeNewswire
    ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023
    Via InvestorPlace
    Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.